General
Oxford University to launch trial alternating coronavirus vaccines from AstraZeneca and Pfizer-BioNTech
Oxford University says it will launch a trial alternating doses of COVID-19 vaccines created by different manufacturers.
Key points:
- The trial aims to determine whether different COVID-19 doses can be used interchangeably
- If successful, it could lead to a more flexible vaccine rollout, says the UK’s chief health officer
- Britain has been administering vaccines at an interval of 12 weeks to give more people a first dose, unlike other countries
The trial aims to determine whether different COVID-19 vaccine doses — those created by the AstraZeneca and Pfizer-BioNTech pharmaceutical companies — can be used interchangeably.
If successful it could allow greater flexibility in pressured vaccine delivery schedules.
The UK’s Deputy Chief Medical…
Continue Reading
-
Noosa News18 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business18 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Business18 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News18 hours agoDid AI write your accounting expert’s report? – Proctor